Lung Transplant Journeys – Patients & Caregivers

Instead of the usual, facilitator-led patient support group meeting that takes place on the first Tuesday of every month at 2:00PM ET, this session will instead feature a live webinar […]

FIBRONEER-IPF – A Phase 3 Clinical Trial

Boehringer Ingelheim has enrolled the first patient in FIBRONEER-IPF, a Phase 3 clinical trial evaluating the efficacy, safety, and tolerability of BI 1015550, an investigational therapy for people with idiopathic […]